表紙
市場調査レポート

血行動態モニタリングシステムの世界市場の分析・予測 (〜2019年):侵襲的血行動態モニタリング・低侵襲的血行動態モニタリング・非侵襲的血行動態モニタリング

Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019

発行 MarketsandMarkets 商品コード 325609
出版日 ページ情報 英文 153 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
血行動態モニタリングシステムの世界市場の分析・予測 (〜2019年):侵襲的血行動態モニタリング・低侵襲的血行動態モニタリング・非侵襲的血行動態モニタリング Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019
出版日: 2015年03月05日 ページ情報: 英文 153 Pages
概要

血行動態モニタリングシステム市場の成長は、システム技術の進歩、高血圧および糖尿病有病率の増加、急速な高齢化などの要因によって加速する見通しです。さらに中国やインドなど、人口の多い国での高齢化が大きな市場機会をもたらすでしょう。しかしながら、侵襲的システムに関連するリスクが市場成長を阻害する要因となっています。世界の血行動態モニタリングシステムの市場は2014年の11億740万ドルから4.5%のCAGRで推移し、2019年には88億7800万ドルの規模に成長すると予測されています。

当レポートでは、世界の血行動態モニタリングシステムの市場について調査し、市場背景および市場構造、製品タイプの種類と概要、製品区分・タイプ・エンドユーザー別の市場規模の推移と予測、地域別の動向、市場成長への各種影響因子の分析、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 魅力的な市場機会
  • 世界の血行動態モニタリングシステム市場
  • 地域・タイプ別市場
  • 地域概要
  • タイプ別市場の現状と予測

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 市場成長推進因子
    • 市場成長阻害因子
    • 市場機会

第6章 産業動向

  • ポーターのファイブフォース分析
  • サプライチェーン分析

第7章 血行動態モニタリングシステムの世界市場:製品タイプ別

  • イントロダクション
  • システム (モニター)
    • ディスプレイシステム
      • 製品
    • 統合血行動態モニタリングシステム
      • 製品
  • ディスポーザブル製品
    • バルーンカテーテル
      • 製品
    • 測定プローブ
      • 製品
    • センサー
      • 製品
    • ガイドワイヤー
      • 製品

第8章 血行動態モニタリングシステムの世界市場:タイプ別

  • イントロダクション
  • 侵襲的血行動態モニタリングシステム
    • 用途
    • リスク
    • 製品
  • 低侵襲的システム
    • 用途
    • 製品
  • 非侵襲的システム
    • 製品

第9章 血行動態モニタリングシステムの世界市場:エンドユーザータイプ別

  • イントロダクション
  • 病院
  • カテーテル室
  • 自宅・外来診療所

第10章 地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他
    • ラテンアメリカ
    • 中東・アフリカ
    • 太平洋地域

第11章 競合環境

  • 概要
  • 市場シェア分析
    • Edwards Lifesciences Corporation
    • Pulsion Medical Systems Se
    • Lidco Group PLC
  • 競合状況・動向
    • 合意・提携・協力
    • 拡張
    • M&A
    • 新製品の投入
    • その他

第12章 企業プロファイル

  • イントロダクション
  • Cheetah Medical, Inc.
  • Deltex Medical Group PLC
  • Edwards Lifesciences Corporation
  • HEMO Sapiens, Inc.
  • ICU Medical, Inc.
  • Lidco Group PLC
  • Osypka Medical GMBH
  • Pulsion Medical Systems Se
  • Schwarzer Cardiotek GMBH
  • Tensys Medical, Inc.
    • 概要
    • 製品ポートフォリオ
    • 主要戦略
    • 発展動向、など

第13章 付録

目次
Product Code: MD 3211

Over the years, the hemodynamic monitoring systems market has witnessed various technological advancements in order to better serve the critically ill patients. These advancements have led to the development of minimally invasive and noninvasive hemodynamic monitoring systems with an aim to reduce pain, increase comfort, and most importantly reduce infectious diseases, primarily sepsis.

In 2014, the disposables segment accounted for the largest share of the global hemodynamic monitoring systems market, by product; the invasive hemodynamic monitoring systems segment accounted for the largest share of the hemodynamic monitoring systems market, by type; while the hospitals segment accounted for a major share of the hemodynamic monitoring system market, by end user.

In 2014, North America accounted for the largest share of the global hemodynamic monitoring systems market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the hemodynamic monitoring systems market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of hemodynamic monitoring systems.

The global hemodynamic monitoring systems market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hemodynamic monitoring systems market. The report analyzes hemodynamic monitoring systems by product, by type, and by end-user
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the hemodynamic monitoring systems market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring system technologies across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the hemodynamic monitoring systems market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the hemodynamic monitoring systems market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Package Size
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1.1. Research Methodology Steps
  • 2.1.2. Secondary and Primary Research Methodology
    • 2.1.2.1. Secondary Research
  • 2.1.3. Key Data From Secondary Sources
    • 2.1.3.1. Primary Research
    • 2.1.3.2. Key Industry Insights
  • 2.1.4. Key Data From Primary Sources
  • 2.1.5. Key Insights From Primary Sources
  • 2.1.6. Market Size Estimation Methodology
  • 2.1.7. Market Forecast Methodology
  • 2.1.8. Market Data Validation and Triangulation
  • 2.1.9. Assumptions

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Current Scenario
  • 3.3. Future Outlook
  • 3.4. Conclusion

4. Premium Insights

  • 4.1. Global Hemodynamic Monitoring Systems Market
  • 4.2. Market, By Region and Type
  • 4.3. Regional Snapshot of the Market
  • 4.4. Market, By Type (2014 vs. 2019)

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Technological Advancements in Systems
        • 5.3.1.1.1. Non-Invasive Hemodynamic Monitoring Systems
        • 5.3.1.1.2. Micro-Electro-Mechanical Systems (Mems) Technology
      • 5.3.1.2. Growth in the Number of People Suffering From Hypertension
      • 5.3.1.3. Growing Diabetic Population
      • 5.3.1.4. Rapid Growth in Aging Population
    • 5.3.2. Restraint
      • 5.3.2.1. Risks Associated With Invasive Hemodynamic Monitoring
    • 5.3.3. Opportunity
      • 5.3.3.1. India and China to Provide Significant Growth Opportunities for the Market

6. Industry Insights

  • 6.1. Porter's Five Forces Analysis
    • 6.1.1. Supplier's Bargaining Power
      • 6.1.1.1. Presence of Large Number of Suppliers
      • 6.1.1.2. Low Dependency on Single Supplier
      • 6.1.1.3. Dependency on Type of Technology
    • 6.1.2. Buyer's Bargaining Power
      • 6.1.2.1. Large Supplier Pool
    • 6.1.3. Threat of New Entrants
      • 6.1.3.1. Capital-Intensive Market
      • 6.1.3.2. Stronghold of Existing Players
      • 6.1.3.3. Reimbursement Coverage
    • 6.1.4. Threat of Substitutes
      • 6.1.4.1. Lack of Alternatives
    • 6.1.5. Intensity of Competitive Rivalry
      • 6.1.5.1. Presence of Large Number of Small Firms
  • 6.2. Supply Chain Analysis
    • 6.2.1. Prominent Companies
    • 6.2.2. Small and Medium Enterprises
    • 6.2.3. End Users (Patients/Hospitals/Labs/Clinics)
    • 6.2.4. Key Influencers

7. Hemodynamic Monitoring System Market, By Product

  • 7.2. Introduction
  • 7.3. Systems (Monitors)
    • 7.3.1. Display Systems
      • 7.3.1.1. Products
    • 7.3.2. Unified Hemodynamic Monitoring Systems
      • 7.3.2.1. Products
  • 7.4. Disposables
    • 7.4.1. Balloon Catheters
      • 7.4.1.1. Products
    • 7.4.2. Measurement Probes
      • 7.4.2.1. Products
    • 7.4.3. Sensors
      • 7.4.3.1. Products
    • 7.4.4. Guidewires
      • 7.4.4.1. Products

8. Hemodynamic Monitoring System Market, By Type

  • 8.1. Introduction
  • 8.2. Invasive Hemodynamic Monitoring Systems
    • 8.2.1. Applications of Invasive Systems
    • 8.2.2. Risks Associated With Invasive Hemodynamic Monitoring
    • 8.2.3. Products
  • 8.3. Minimally Invasive Systems
    • 8.3.1. Applications
    • 8.3.2. Products
  • 8.4. Noninvasive Systems
    • 8.4.1. Products

9. Hemodynamic Monitoring System Market, By End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Catheterization Laboratories (Cath Labs)
  • 9.4. Home and Ambulatory Sites

10. Hemodynamic Monitoring System Market, By Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
      • 10.2.1.1. Growing Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
      • 10.2.1.2. Reimbursement Offerings By Companies to Drive the Market
    • 10.2.2. Canada
      • 10.2.2.1. High Diabetes Prevalence to Boost the Market for Hemodynamic Monitoring Systems
  • 10.3. Europe
    • 10.3.1. Germany
      • 10.3.1.1. High Diabetes Prevalence to Accelerate the Market Growth in Germany
      • 10.3.1.2. S3 Guidelines for Intensive Care in Cardiac Surgeries
    • 10.3.2. U.K.
      • 10.3.2.1. Rising Prevalence of Diabetes and Cardiovascular Diseases in the U.K.
    • 10.3.3. Rest of Europe (RoE)
      • 10.3.3.1. SFAR Guidelines in France Have Made Odm (Oesophageal Doppler Monitor) A Standard of Care in the Country
      • 10.3.3.2. High Diabetes Prevalence in Russia, Turkey, Poland, Romania, and Ukraine to Propel the Market for Hemodynamic Monitoring Systems in These Countries
  • 10.4. Asia
    • 10.4.1. Japan
      • 10.4.1.1. Reimbursement Offerings By Lidco Group PLC in Japan to Propel the Market Growth
    • 10.4.2. China
      • 10.4.2.1. High Diabetes Incidence and Rapidly Aging Population to Drive the Market in China
    • 10.4.3. India
      • 10.4.3.1. Increased Demand for Critical Care Units and High Diabetes Incidence to Drive the Market in India
    • 10.4.4. Rest of Asia
      • 10.4.4.1. Adoption of Hemodynamic Monitoring Systems in Vietnam, Singapore, & Malaysia to Increase Owing to High Diabetes Prevalence
      • 10.4.4.2. Tensys Medical's Strong Marketing Strategy to Bolster the Market for Non-Invasive Hemodynamic Monitoring in China and Taiwan
  • 10.5. Rest of the World (RoW)
    • 10.5.1. Latin America
      • 10.5.1.1. High Diabetes Prevalence in Brazil
    • 10.5.2. Middle East and Africa
      • 10.5.2.1. Rise in Adoption of Hemodynamic Monitoring Systems in the Middle East & Africa Due to High Diabetes Prevalence
    • 10.5.3. Pacific Countries
      • 10.5.3.1. High Diabetes Prevalence and Rising Incidence of Cvds to Drive the Growth of Hemodynamic Monitoring Systems in Pacific Countries

11. Competitive Landscape

  • 11.1. Overview
  • 11.2. Market Share Analysis
    • 11.2.1. Edwards Lifesciences Corporation
    • 11.2.2. Pulsion Medical Systems Se
    • 11.2.3. Lidco Group PLC
  • 11.3. Competitive Situation and Trends
    • 11.3.1. Agreements, Partnerships, Joint Ventures, and Collaborations
    • 11.3.2. Expansions
    • 11.3.3. Mergers and Acquisitions
    • 11.3.4. New Product Launches
    • 11.3.5. Others

12. Company Profiles

  • 12.1. Introduction
  • 12.2. Cheetah Medical, Inc.
    • 12.2.1. Business Overview
    • 12.2.2. Product Portfolio
    • 12.2.3. Key Strategy
    • 12.2.4. Recent Developments
  • 12.3. Deltex Medical Group PLC
    • 12.3.1. Business Overview
    • 12.3.2. Deltex Medical Group PLC: Company Snapshot
    • 12.3.3. Product Portfolio
    • 12.3.4. Key Strategy
    • 12.3.5. Recent Developments
  • 12.4. Edwards Lifesciences Corporation
    • 12.4.1. Business Overview
    • 12.4.2. Edwards Lifesciences Corporation: Company Snapshot
    • 12.4.3. Product Portfolio
    • 12.4.4. Key Strategy
    • 12.4.5. Recent Developments
  • 12.5. HEMO Sapiens, Inc.
    • 12.5.1. Business Overview
    • 12.5.2. Product Portfolio
    • 12.5.3. Key Strategy
  • 12.6. ICU Medical, Inc.
    • 12.6.1. Business Overview
    • 12.6.2. ICU Medical, Inc.: Company Snapshot
    • 12.6.3. Product Portfolio
    • 12.6.4. Key Strategy
    • 12.6.5. Recent Developments
  • 12.7. Lidco Group PLC
    • 12.7.1. Business Overview
  • 12.8. 1.5.2. Lidco Group PLC: Company Snapshot
    • 12.8.1. Product Portfolio
    • 12.8.2. Key Strategy
    • 12.8.3. Recent Developments
  • 12.9. Osypka Medical GMBH
    • 12.9.1. Business Overview
    • 12.9.2. Product Portfolio
    • 12.9.3. Key Strategy
    • 12.9.4. Recent Developments
  • 12.1. Pulsion Medical Systems Se
    • 12.10.1. Business Overview
    • 12.10.2. Pulsion Medical Systems Se: Company Snapshot
    • 12.10.3. Product Portfolio
    • 12.10.4. Key Strategy
    • 12.10.5. Recent Developments
  • 12.11. Schwarzer Cardiotek GMBH
    • 12.11.1. Business Overview
    • 12.11.2. Product Portfolio
    • 12.11.3. Key Strategy
    • 12.11.4. Recent Development
  • 12.12. Tensys Medical, Inc.
    • 12.12.1. Business Overview
    • 12.12.2. Product Portfolio
    • 12.12.3. Key Strategy
    • 12.12.4. Recent Developments

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. Company Developments (2012-2014)
    • 13.2.1. Lidco Group PLC
  • 13.3. Introducing RT: Real-Time Market Intelligence
  • 13.4. Available Customizations
  • 13.5. Related Reports

List of Tables

  • Table 1: Top 10 Countries/Territories With the Highest Number of Diabetics (Aged 20-79 Years), 2013 vs. 2035
  • Table 2: Growth in the Number of People Suffering From Hypertension Driving the Growth of the Hemodynamics Monitoring Systems Market
  • Table 3: Risks Associated With Invasive Hemodynamic Monitoring Are Restraining the Growth of the Market
  • Table 4: India and China to Provide Significant Growth Opportunities for the Market
  • Table 5: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 6: Hemodynamic Monitors Market Size, By Region, 2012-2019 ($Million)
  • Table 7: North America: Hemodynamic Monitors Market Size, By Country, 2012-2019 ($Million)
  • Table 8: Europe: Hemodynamic Monitors Market Size, By Country, 2012-2019 ($Million)
  • Table 9: Asia: Hemodynamic Monitors Market Size, By Country, 2012-2019 ($Million)
  • Table 10: RoW: Hemodynamic Monitors Market Size, By Region, 2012-2019 ($Million)
  • Table 11: Hemodynamic Monitoring Disposables Market Size, By Region, 2012-2019 ($Million)
  • Table 12: North America: Hemodynamic Monitoring Disposables Market Size, By Country, 2012-2019 ($Million)
  • Table 13: Europe: Hemodynamic Monitoring Disposables Market Size, By Country, 2012-2019 ($Million)
  • Table 14: Asia: Hemodynamic Monitoring Disposables Market Size, By Country, 2012-2019 ($Million)
  • Table 15: RoW: Hemodynamic Monitoring Disposables Market Size, By Region, 2012-2019 ($Million)
  • Table 16: Hemodynamic Monitoring Systems Market Size, By Type, 2012-2019 ($Million)
  • Table 17: Market Size, By Type, 2012-2019 (Units)
  • Table 18: Market Size, By Region, 2012-2019 (Units)
  • Table 19: Invasive Hemodynamic Monitoring Systems Market Size, By Region, 2012-2019 ($Million)
  • Table 20: Invasive Systems Market Size, By Region, 2012-2019 (Units)
  • Table 21: North America: Invasive Systems Market Size, By Country, 2012-2019 ($Million)
  • Table 22: Europe: Invasive Systems Market Size, By Country, 2012-2019 ($Million)
  • Table 23: Asia: Invasive Systems Market Size, By Country, 2012-2019 ($Thousand)
  • Table 24: RoW: Invasive Systems Market Size, By Region, 2012-2019 ($Thousand)
  • Table 25: Minimally Invasive Systems Market Size, By Region, 2012-2019 ($Million)
  • Table 26: Minimally Invasive Systems Market Size, By Region, 2012-2019 (Units)
  • Table 27: North America: Minimally Invasive Hemodynamic Monitoring Systems Market Size, By Country, 2012-2019 ($Million)
  • Table 28: Europe: Minimally Invasive Systems Market Size, By Country, 2012-2019 ($Million)
  • Table 29: Asia: Minimally Invasive Systems Market Size, By Country, 2012-2019 ($Million)
  • Table 30: RoW: Minimally Invasive Market Size, By Region, 2012-2019 ($Thousand)
  • Table 31: Non Invasive Hemodynamic Monitoring Systems Market Size, By Region, 2012-2019 ($Thousand)
  • Table 32: Non Invasive Systems Market Size, By Region, 2012-2019 (Units)
  • Table 33: North America: Non Invasive Systems Market Size, By Country, 2012-2019 ($Thousand)
  • Table 34: Europe: Non Invasive Systems Market Size, By Country, 2012-2019 ($Thousand)
  • Table 35: Asia: Non Invasive Systems Market Size, By Country, 2012-2019 ($Thousand)
  • Table 36: RoW: Non Invasive Systems Market Size, By Region, 2012-2019 ($Thousand)
  • Table 37: Market Size, By End User, 2012-2019 ($Million)
  • Table 38: North America: Market Size, By Country, 2012-2019 ($Million)
  • Table 39: Europe: Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 40: Asia: Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 41: RoW: Market Size, By Region, 2012-2019 ($Million)
  • Table 42: Hospitals Market Size, By Region, 2012-2019 ($Million)
  • Table 43: North America: Hospitals Market Size, By Country, 2012-2019 ($Million)
  • Table 44: Europe: Hospitals Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 45: Asia: Hospitals Market Size, By Country/Region, 2012-2019 ($Million)
  • Table 46: RoW: Hospitals Market Size, By Region, 2012-2019 ($Million)
  • Table 47: CATH Labs Market Size, By Region, 2012-2019 ($Thousand)
  • Table 48: North America: CATH Labs Market Size, By Country, 2012-2019 ($Thousand)
  • Table 49: Europe: CATH Labs Market Size, By Country/Region, 2012-2019 ($Thousand)
  • Table 50: Asia: CATH Labs Market Size, By Country/Region, 2012-2019 ($Thousand)
  • Table 51: RoW: CATH Labs Market Size, By Region, 2012-2019 ($Thousand)
  • Table 52: Home and Ambulatory Sites Market Size, By Region, 2012-2019 ($Thousand)
  • Table 53: North America: Home and Ambulatory Sites Market Size, By Country, 2012-2019 ($Thousand)
  • Table 54: Europe: Home and Ambulatory Sites Market Size, By Country/Region, 2012-2019 ($Thousand)
  • Table 55: Asia: Home and Ambulatory Sites Market Size, By Country/Region, 2012-2019 ($Thousand)
  • Table 56: RoW: Home and Ambulatory Sites Market Size, By Region, 2012-2019 ($Thousand)
  • Table 57: Hemodynamic Monitoring Systems Market Size, By Region, 2012-2019 ($Million)
  • Table 58: North America: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 59: North America: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 60: North America: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 61: U.S.: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 62: U.S.: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 63: U.S.: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 64: Canada: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 65: Canada: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 66: Canada: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 67: Europe: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 68: Europe: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 69: Europe: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 70: Germany: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 71: Germany: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 72: Germany: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 73: Average Prevalence of Diabetes in the U.K. in Adults is 6.0% (2013)
  • Table 74: U.K.: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 75: U.K.: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 76: U.K.: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 77: RoE: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 78: RoE: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 79: RoE: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 80: Asia: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 81: Asia: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 82: Asia: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 83: Japan: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 84: Japan: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 85: Japan: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 86: China: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 87: China: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 88: China: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 89: India: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 90: India: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 91: India: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 92: RoA: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Million)
  • Table 93: RoA: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 94: RoA: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 95: RoW: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Thousand)
  • Table 96: RoW: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 97: RoW: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 98: Latin America: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Thousand)
  • Table 99: Latin America: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 100: Latin America: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 101: Middle East and Africa: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Thousand)
  • Table 102: Middle East and Africa: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 103: Middle East and Africa: Market Size, By End-User, 2012-2019 ($Thousand)
  • Table 104: Pacific Countries: Hemodynamic Monitoring Systems Market Size, By Product, 2012-2019 ($Thousand)
  • Table 105: Pacific Countries: Market Size, By Type, 2012-2019 ($Thousand)
  • Table 106: Pacific Countries: Market Size, By End User, 2012-2019 ($Thousand)
  • Table 107: Recent Developments, 2012-2014
  • Table 108: Recent Developments, 2012-2014
  • Table 109: Recent Developments, 2012-2014
  • Table 110: Recent Developments, 2012-2014
  • Table 111: Recent Developments, 2012-2014

List of Figures

  • Figure 1: Global Hemodynamic Monitoring Systems Market : Research Methodology Steps
  • Figure 2: Sampling Frame: Primary Research
  • Figure 3: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 5: Market Size Estimation Methodology: Top-Down Approach
  • Figure 6: Market Forecast Methodology
  • Figure 7: Data Triangulation Methodology
  • Figure 8: Minimally Invasive Hemodynamic Monitoring Systems Market to Witness the Highest CAGR of 6.0% From 2014 to 2019
  • Figure 9: Disposables Segment to Grow at the Highest CAGR From 2014-2019
  • Figure 10: Hospitals End-User Segment Dominates the Market
  • Figure 11: Asia is Slated to Witness the Highest Growth in the Hemodynamic Monitoring System Market
  • Figure 12: Market Overview
  • Figure 13: North America Dominated the Market in 2014
  • Figure 14: Asia to Witness the Highest Growth Rate During the Forecast Period
  • Figure 15: Invasive Systems Commanded the Largest Share
  • Figure 16: Market Segmentation
  • Figure 17: Market: Drivers, Restraints, and Opportunities
  • Figure 18: Porter's Five Forces Analysis: Hemodynamic Monitoring Systems Market
  • Figure 19: Supply Chain: Direct Distribution is the Most Preferred Strategy
  • Figure 20: Followed By Prominent Players
  • Figure 21: Disposables Market Expected to Grow at A Higher Rate During The forecast Period
  • Figure 22: Invasive Hemodynamic Monitoring Systems Commanded Largest Market Share in 2014
  • Figure 23: Hospitals Segment Dominated the Hemodynamic Monitoring Systems Market
  • Figure 24: North America to Command the Largest Share of the Global Market
  • Figure 25: U.S. to Witness the Highest Growth in the Market in North America
  • Figure 26: Germany to Witness the Highest Growth in the Market in Europe
  • Figure 27: Europe: Number of Diabetics, By Country, 2012
  • Figure 28: China is the Fastest-Growing Market in Asia
  • Figure 29: RoW Accounted for A Share of 10.5% of the Market in 2014
  • Figure 30: Expansions Was the Key Growth Strategy Adopted By Market Players Between 2011 and 2014
  • Figure 31: Market Share Analysis of the Global Market, By Key Player, 2014
  • Figure 32: Battle for Market Share: Agreements, Partnerships, Joint Ventures, and Collaborations Was the Key Strategy
  • Figure 33: Geographical Revenue Mix of the Top 3 Players
  • Figure 34: Company at A Glance
  • Figure 35: Company at A Glance
  • Figure 36: Company at A Glance
  • Figure 37: Company at A Glance
  • Figure 38: Company at A Glance
  • Figure 39: Company at A Glance
  • Figure 40: Company at A Glance
  • Figure 41: Company at A Glance
  • Figure 42: Company at A Glance
  • Figure 39: Company at A Glance
Back to Top